E-resources
Peer reviewed
-
Ibrahim, Weam W.; Skalicka-Woźniak, Krystyna; Budzyńska, Barbara; El Sayed, Nesrine S.
International immunopharmacology, June 2023, 2023-Jun, 2023-06-00, 20230601, Volume: 119Journal Article
Illustrating the role of inhibiting TLR4/MyD88/NF-κB/NLRP3 and driving microglia polarization towards M2 in the neuroprotective and memory-improving effects of scoparone in OVX/D-Gal rats. Scoparone reduces OVX/D-Gal-induced Aβ aggregation and tau hyperphosphorylation. It exerts its anti-inflammatory and neuroprotective effects via inhibiting TLR4/MyD88/TRAF-6/TAK-1 pathway and consequently inhibits the downstream effectors, NF-κB and JNK. Moreover, inhibition of NF-κB by scoparone abrogates the NLRP3 inflammasome activation and in turn mitigates caspase-1 production and IL-1β/18 secretion. Further, scoparone-induced inhibition of NLRP3 suppresses the neurotoxic M1 while enhances the neuroprotective M2 activated microglia markers. These effects contribute to scoparone’s ability to reduce neuro-inflammation, neuronal degeneration, Aβ aggregation, and tau hyperphosphorylation. D-Gal D-galactose, OVX ovariectomy, Aβ amyloid-β, TLR4 toll-like receptor 4, MyD88 myeloid differentiation factor 88, TRAF-6 tumor necrosis factor (TNF) receptor-associated factor-6, TAK-1 transforming growth factor-β (TGF-β)-activated kinase-1, NF-κB nuclear factor-κB, JNK c-Jun N-terminal Kinase, NLRP3 nucleotide-binding oligomerization domain (NOD)-like receptor protein 3, IL-18 interleukin-18, IL-1β interleukin-1β, CD cluster of differentiation. Display omitted •Scoparone mitigated OVX/D-Gal-induced neuroinflammation and Alzheimer’s hallmarks.•Scoparone improved rats’ memory functions and the hippocampal photomicrographs.•Modulation of TLR4 axis by scoparone is a core signaling in mediating its effects.•NLRP3 inhibition and M2 microglial shifting underlie scoparone’s neuroprotection.•Scoparone is a prosperous candidate for Alzheimer’s disease management. Neuroinflammation mediated by microglia activation is a critical contributor to Alzheimer's disease (AD) pathogenesis. Dysregulated microglia polarization in terms of M1 overactivation with M2 inhibition is involved in AD pathological damage. Scoparone (SCO), a coumarin derivative, displays several beneficial pharmacological effects including anti-inflammatory and anti-apoptotic properties, however, its neurological effect in AD is still elusive. This study investigated the neuroprotective potential of SCO in AD animal model focusing on determining its effect on M1/M2 microglia polarization and exploring the plausible mechanism involved via investigating its modulatory role on TLR4/MyD88/NF-κB and NLRP3 inflammasome. Sixty female Wistar rats were randomly allocated into four groups. Two groups were sham-operated and treated or untreated with SCO, and the other two groups were subjected to bilateral ovariectomy (OVX) and received D-galactose (D-Gal; 150 mg/kg/day, i.p) alone or with SCO (12.5 mg/kg/day, i.p) for 6 weeks. SCO improved memory functions of OVX/D-Gal rats in the Morris water maze and novel object recognition tests. It also reduced the hippocampal burden of amyloid-β42 and p-Tau, additionally, the hippocampal histopathological architecture was prominently preserved. SCO inhibited the gene expression of TLR4, MyD88, TRAF-6, and TAK-1, additionally, p-JNK and NF-κBp65 levels were significantly curbed. This was associated with repression of NLRP3 inflammasome along with M1-to-M2 microglia polarization shifting as exemplified by mitigating pro-inflammatory M1 marker (CD86) and elevating M2 neuroprotective marker (CD163). Therefore, SCO could promote microglia transition towards M2 through switching off TLR4/MyD88/TRAF-6/TAK-1/NF-κB axis and inhibiting NLRP3 pathway, with consequent mitigation of neuroinflammation and neurodegeneration in OVX/D-Gal AD model.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.